Numerous people believe cannabis to be a successful cancer cure.
By federal law, possessing cannabis (marijuana) is illegal in the United States unless it is used in approved research settings. Yet, a growing number of states, territories, and the District of Columbia have passed laws to legalize medical marijuana.
The main psychoactive cannabinoid in Cannabis is delta-9-THC, while another active cannabinoid, cannabidiol (CBD), might alleviate pain and lower inflammation without causing the high of delta-9-THC.
The website of The National Cancer Institute, which is part of the US Department of Health, indicates that ‘cannabinoids may be useful in treating the side effects of cancer and cancer treatment’.
The website also adds that no ongoing studies of cannabis as a treatment for cancer in people have been found in the CAM on PubMed database maintained by the National Institutes of Health. Yet, small studies have been done, but their results have not been reported or suggest a need for larger studies.
Cannabis and cannabinoids have been studied as ways to manage side effects of cancer and cancer therapies, including pain, nausea, appetite loss, as well as pain, and anxiety.
The National Cancer Institute suggests that laboratory and animal studies have shown that cannabinoids may be able to kill cancer cells while protecting normal cells. They may inhibit tumor growth by causing cell death, inhibiting cell growth, and blocking the development of blood vessels needed by tumors to grow.
Yet, researchers added that at the time, there is a lack of evidence that recommends patients to inhale or ingest cannabis as a treatment for cancer-related symptoms or side effects of cancer therapy.
Cannabis has been commonly used by patients diseased with some type of cancer as a way to alleviate pain in numerous US states where it is legal for medicinal application.
However, The Cancer Research Charity cautiously explains that there isn’t enough reliable evidence to prove that cannabinoids, whether natural or synthetic, can effectively treat cancer in patients, although research is ongoing around the world.
Therefore, even though cannabis and its derivatives may help to alleviate disease- and therapy-related symptoms, there is still no clinical evidence of its anti-cancer efficacy.
Also, one 2014 study on using cannabinoids and radiotherapy to tackle aggressive brain cancer has shown promising results, but we are still at the “inconclusive evidence” stage.
The FDA says that the claims that certain CBD-based products can kill off cancer cells or combat tumors in any way are simply unfounded, and companies should stop advertising them as anything close to being cures for cancer.
Yet, the FDA also points out that we still don’t know enough about cannabis, but the recent moves to legalize it urge scientists to gather detailed evidence about its effects on our body.
The agency also published a consumer update on its website to address some of the numerous claims surrounding this prevalent cannabinoid and attempts to dispel the notion that it is some kind of risk-free miracle drug.
On the website, the FDA claims that it recognizes the significant public interest in cannabis and cannabis-derived compounds, particularly CBD, but there are many unanswered questions about the science, safety, and quality of products containing it. Therefore, they now work on answering them.
It adds that CBD products are still subject to the same laws and requirements as FDA-regulated products that contain any other substance. Moreover, the FDA explains that it has not approved the use of any other CBD product that the one prescription drug product used to treat rare, severe forms of epilepsy.